The story has been updated to include comments from Qiagen's conference call Wednesday morning.

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Tuesday a 6 percent increase in revenues year over year for its third quarter.

Total revenues for the three months ended Sept. 30 reached $322.1 million, up from $304.3 million a year ago, and beating the average analyst estimate of $320.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.